World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: REBEC
Last refreshed on: 29 April 2013
Main ID:  RBR-249vpp
Date of registration: 13/02/2012
Primary sponsor: Pontifícia Universidade Católica de Campinas - PUCCAMP - Brazil
Public title: Comparison between the analgesics ketoprofen and parecoxib for pain control after gallbladder surgical removal
Scientific title: Postoperative analgesia: comparison between ketoprofen and parecoxib in patients submitted to conventional cholecystectomy
Date of first enrolment: 10/01/2010
Target sample size: 55
Recruitment status: data analysis completed
URL:  http://www.ensaiosclinicos.gov.br/rg/RBR-249vpp/
Study type: 
Study design:  Dual-arm clinical trial, randomized, double-blind, phase 4.  
Countries of recruitment
Brazil
Contacts
Name: Jose  Orosz
Address:  Av. Washington Luiz 1800 13042105 Campinas Brazil
Telephone: 551981118904
Email: je.orosz@terra.com.br
Affiliation:  PUCCAMP
Name: Jose   Orosz
Address:  Av. Washington Luiz 1800 13042105 Campinas Brazil
Telephone: 551981118904
Email: je.orosz@terra.com.br
Affiliation:  PUCCAMP
Key inclusion & exclusion criteria
Inclusion criteria: Physical status ASA 1 or 2 patients, undergoing conventional cholecystectomy, of both genders, aged 18 to 55 years old.
Exclusion criteria: ASA Physical Status 3, 4 or 5.
Patients using hormonal or nonhormonal anti-inflammatory drugs.


Age minimum: 18Y
Age maximum: 65Y
Gender: -
Health Condition(s) or Problem(s) studied
Post operative pain
C10.597.617
Intervention(s)
This prospective double blind study will include 55 physical status ASA 1 or 2 patients, undergoing conventional cholecystectomy, of both genders, aged 18 to 55 years old, allocated in a random and covert way in the groups: C - which will receive IV ketoprofen at a dose of 100 mg and P - which will receive parecoxib 40 mg IV dose. Patients from both groups will be submitted to total intravenous general anesthesia, induced with sufentanil 1 mcg/kg, cis-atracurium 0.15 mg/kg and propofol 3 mg/kg, and maintained with remifentanil 0.1 mcg/kg/min and propofol 3mg/kg/h . In the postoperative period patients will be assessed for the presence of pain on arrival to the post-anesthesia care unit (PACU), and after 1, 2, 4, 6 and 12 hours, using the analog pain scale (APS). Possible need for additional analgesia will be made with 1mg/kg tramadol IV and dipyrone 2g IV and also analyzed.
Primary Outcome(s)
Cholecystectomy
Secondary Outcome(s)
Postoperative pain, assessed by the patient via analog scale of pain.
Secondary ID(s)
144604
757/08
Source(s) of Monetary Support
Pontifícia Universidade Católica de Campinas - PUCCAMP - Brazil
Secondary Sponsor(s)
Pontifícia Universidade Católica de Campinas - PUCCAMP - Brazil
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history